000			02862nam a22003495i 4500
001			82096
003			ES-MaUEC
005			20230207040355.0
007			cr nn 008mamaa
008			150609s2015 xxk| s |||| 0|eng d
020			_a9781907673917
024	7		_a10.1007/978-1-907673-91-7 _2doi
050		4	_aRC933 _b2015 EB
245	1	0	_aAtlas of Rheumatoid Arthritis _cedited by Paul Emery.
260			_aTarporley _bSpringer _c2015
300			_a1 recurso en línea (XI, 264 páginas) _b166 ilustraciones, 115 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aClassification of rheumatoid arthritis -- Pre-rheumatoid arthritis -- Early rheumatoid arthritis -- Established rheumatoid arthritis -- Remission and rheumatoid arthritis -- Magnetic resonance imaging in rheumatoid arthritis -- Ultrasound imaging in rheumatoid arthritis -- Dual energyÂ{u8B72}ay absorptiometry in rheumatoid arthritis -- Methotrexate -- Immunotherapy -- Rituximab.-Â{uEBF6}vel therapies in rheumatoid arthritis: small molecules.
520	3		_aAtlas of Rheumatoid Arthritis is a high-quality educational initiative, written by leaders in the field of rheumatology, containing a collection of approximately 150 relevant images, with extended descriptive captions and a comprehensive bibliography. The Atlas of Rheumatoid Arthritis will provide clinicians with a visual guide to rheumatoid arthritis, focusing on assessment, diagnosis and treatment, including newer research into the signalling pathways involved in the pathogenesis of RA, before focusing on the treatment of RA. Rheumatoid arthritis (RA) is the most common and most serious of the inflammatory arthritic disorders, and it dominates clinical rheumatological practice. Effective, early treatment is vital as this can slow the course of the disease and reduce joint damage. RA is usually treated using disease-modifying anti-rheumatic drugs (DMARDs), most commonly methotrexate. The newest treatments target the disease-causing immune elements specifically and directly.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		7	_aReumatología _0 _2embne _9141883
650	2	7	_aReumatología _0 _2embne _9141883
700	1		_aEmery, Paul _eeditor literario _934342 _0comprobar BNE20021940756
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-907673-91-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12907364 _b10-10-17 _c10-02-16
988			_aSpringer_Medicine_2015
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _gxxk _h0
945			_aRC933 .A853 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11575049 _z06-04-17
999			_c82096 _d82096 _x1